Study Finds FDA Falling Short of Drug Safety Expectations

Law360, New York (September 25, 2006, 12:00 AM EDT) -- A recent study by the Institute of Medicine has found that the Food and Drug Administration has fallen short of its task of making sure that drugs that come to the market are safe for use.

The FDA commissioned the IOM to do the report following a slew of incidents involving drug-safety, including the withdrawal of painkiller Vioxx from the market over concerns that the drug increased the risk of heart attacks.

The report, entitled The Future of Drug Safety: Promoting and Protecting the Health of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.